MERSANA THERAPEUTICS INC (MRSN) Stock Analyst Earnings Estimates
NASDAQ:MRSN - Nasdaq - US59045L1061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 40K -95.18% | 26.58M 66,350.00% | 36.855M 38.66% | 32.334M -12.27% | 28.346M -12.33% | 48.233M 70.16% | 28.791M -40.31% | 120.15M 317.32% | 354.04M 194.67% | 596.65M 68.53% | 699.59M 17.25% | 788.68M 12.73% | |
| EBITDA YoY % growth | -168M -92.88% | -202.84M -20.74% | -169.44M 16.47% | -76.906M 54.61% | -77.991M -1.41% | -94.119M -20.68% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -168.86M -91.65% | -203.77M -20.67% | -170.957M 16.10% | -79.687M 53.39% | -96.089M -20.58% | -111.67M -16.21% | -121.449M -8.76% | -54.395M 55.21% | 112.85M 307.46% | 345.72M 206.35% | 403.81M 16.80% | 450.75M 11.62% | |
| Operating Margin | -422,150.00% | -766.63% | -463.86% | -246.45% | -338.99% | -231.52% | -421.83% | -45.27% | 31.87% | 57.94% | 57.72% | 57.15% | |
| EPS YoY % growth | -2.40 -67.83% | -2.19 8.75% | -1.42 35.16% | -0.62 56.25% | -0.70 -12.78% | -0.75 -6.52% | -0.84 -12.09% | -0.45 46.34% | 1.17 361.36% | 2.40 104.35% | 2.91 21.28% | 3.21 10.53% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 -1.74% | -0.20 -22.19% | -0.21 -2.85% | -0.21 -138.00% | -0.20 -21.55% |
| Revenue Q2Q % growth | 7.758M -27.50% | 4.488M -51.45% | 4.488M 95.73% | 4.488M -64.38% | 4.488M -42.15% |
| EBITDA Q2Q % growth | -18.104M 6.73% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.054M 8.96% | -23.423M -11.53% | -25.24M 0.85% | -27.105M -124.58% | -28.681M -50.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.09 66.67% | -0.18 | 0.09 | 49.71% |
| Q2 2024 Q2Q % growth | -0.20 57.45% | -0.17 | -0.03 | -14.37% |
| Q1 2024 Q2Q % growth | -0.16 69.23% | -0.18 | 0.02 | 13.34% |
| Q4 2023 Q2Q % growth | -0.16 63.64% | -0.17 | 0.01 | 4.54% |
| Q3 2023 Q2Q % growth | -0.27 55.74% | -0.37 | 0.10 | 26.85% |
| Q2 2023 Q2Q % growth | -0.47 14.55% | -0.45 | -0.02 | -4.38% |
| Q1 2023 Q2Q % growth | -0.52 11.86% | -0.44 | -0.08 | -16.99% |
| Q4 2022 Q2Q % growth | -0.44 35.29% | -0.51 | 0.07 | 14.48% |
| Q3 2022 Q2Q % growth | -0.61 3.17% | -0.09 | -0.52 | -564.49% |
| Q2 2022 Q2Q % growth | -0.55 6.78% | -0.53 | -0.02 | -3.70% |
| Q1 2022 Q2Q % growth | -0.59 -18.00% | -0.32 | -0.27 | -81.57% |
| Q4 2021 Q2Q % growth | -0.68 -61.90% | -0.68 | 0.00 | 0.28% |
| Q3 2021 Q2Q % growth | -0.63 -90.91% | -0.59 | -0.04 | -6.49% |
| Q2 2021 Q2Q % growth | -0.59 -78.79% | -0.51 | -0.08 | -16.07% |
| Q1 2021 Q2Q % growth | -0.50 -42.86% | -0.40 | -0.10 | -24.10% |
| Q4 2020 Q2Q % growth | -0.42 -23.53% | -0.33 | -0.09 | -26.97% |
| Q3 2020 Q2Q % growth | -0.33 5.71% | -0.31 | -0.02 | -6.08% |
| Q2 2020 Q2Q % growth | -0.33 8.33% | -0.30 | -0.03 | -8.45% |
| Q1 2020 Q2Q % growth | -0.35 -150.00% | -0.38 | 0.03 | 7.97% |
| Q4 2019 Q2Q % growth | -0.34 | -0.39 | 0.05 | 12.66% |
| Q3 2019 Q2Q % growth | -0.35 | -0.38 | 0.03 | 8.09% |
| Q2 2019 Q2Q % growth | -0.36 | -0.39 | 0.03 | 7.93% |
| Q1 2019 Q2Q % growth | 0.70 | -0.03 | 0.73 | 2,845.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 12.598M 63.65% | 7.681M | 4.917M | 64.02% |
| Q2 2024 Q2Q % growth | 2.293M -78.48% | 8.896M | -6.603M | -74.22% |
| Q1 2024 Q2Q % growth | 9.245M 18.50% | 8.67M | 575K | 6.63% |
| Q4 2023 Q2Q % growth | 10.701M -27.15% | 15.068M | -4.367M | -28.98% |
| Q3 2023 Q2Q % growth | 7.698M 38.20% | 9.537M | -1.839M | -19.28% |
| Q2 2023 Q2Q % growth | 10.654M 148.93% | 13.214M | -2.56M | -19.37% |
| Q1 2023 Q2Q % growth | 7.802M 282.45% | 18.651M | -10.849M | -58.17% |
| Q4 2022 Q2Q % growth | 14.69M 146,800.00% | 15.589M | -899K | -5.77% |
| Q3 2022 Q2Q % growth | 5.57M 55,600.00% | 35.879M | -30.309M | -84.48% |
| Q2 2022 Q2Q % growth | 4.28M 42,700.00% | 2.246M | 2.034M | 90.56% |
| Q1 2022 Q2Q % growth | 2.04M 20,300.00% | 8.308M | -6.268M | -75.45% |
| Q4 2021 Q2Q % growth | 10K | 3.743K | 6.257K | 167.14% |
| Q3 2021 Q2Q % growth | 10K | 105.356K | -95.356K | -90.51% |
| Q2 2021 Q2Q % growth | 10K -98.75% | 144.503K | -134.503K | -93.08% |
| Q1 2021 Q2Q % growth | 10K | 326.4K | -316.4K | -96.94% |
| Q4 2020 Q2Q % growth | 10K -75.00% | 171.87K | -161.87K | -94.18% |
| Q3 2020 Q2Q % growth | 10K -98.81% | 447.984K | -437.984K | -97.77% |
| Q2 2020 Q2Q % growth | 800K 300.00% | 306K | 494K | 161.44% |
| Q1 2020 Q2Q % growth | 10K -99.98% | 399.503K | -389.503K | -97.50% |
| Q4 2019 Q2Q % growth | 40K | 297.503K | -257.503K | -86.55% |
| Q3 2019 Q2Q % growth | 840K | 297.503K | 542.497K | 182.35% |
| Q2 2019 Q2Q % growth | 200K | 756.503K | -556.503K | -73.56% |
| Q1 2019 Q2Q % growth | 41.04M | 21.016M | 20.024M | 95.28% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.15% | 12.72% | -1.13% | 13.69% |
| Revenue | -0.45% | -8.97% | -0.15% | 24.99% |